Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

Clinical trial NCT02333162 · SUSPENDED

Trial details

NCT number: NCT02333162
Sponsor: University of Chicago
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Hematologic Malignancy

Start date: 2014-12-05
Primary completion: 2028-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.